UnknownPhase 4

Continuous Oxytocin Infusion Versus Pulsatile Intravenous Oxytocin for Augmentation of First Stage of Labor

Egypt120 participantsStarted 2016-03

Plain-language summary

Comparing continuous intravenous oxytocin infusion with pulsatile administration of intravenous oxytocin for augmentation of the first stage of labor.

Who can participate

Age range17 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Women in labor (cervical dilatation 3-4 centimeters) who require augmentation of first stage of labor.
✓. Single viable fetus.
✓. Rupture of membranes before augmentation of labor.
✓. Cephalic presentation.
✓. Term pregnancy.

Exclusion criteria

✕. Malpresentation.
✕. Induction of labor by prostaglandins.
✕. Any uterine previous surgery.
✕. Fetal anomalies.
✕. Premature labor.
✕. Previous cesarean section.
✕. Any uterine anomalies.
✕. Multiple pregnancy.

What they're measuring

duration of active phase of first stage of labor

Timeframe: 24 hours

Trial details

NCT IDNCT02723461

SponsorAin Shams Maternity Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-01

Contact for this trial

Amr A Riad, MD

01005347179 amr.riad@med.asu.edu.eg

View on ClinicalTrials.gov More Failed Induction (of Labor) by Oxytocin trials